BioSpace News Archive

Bedfont Scientific Release: Local Family Business Needs Your Vote to Represent the UK in the European Business Awards

Bedfont Scientific, based in Maidstone, needs the public to vote for them to become a European Public Winner and represent the UK in the European Business Awards.

February 15, 2018

·

2 min read

Genetown

Augmenix, Inc. Announces Aetna’s Positive Coverage Decision for the SpaceOAR Hydrogel Procedure for Men with Prostate Cancer

Augmenix is pleased to announce that Aetna, Inc, the third largest commercial health plan provider in the United States.

February 15, 2018

·

3 min read

NeuroVive Decides on a Rights Issue for Continued Drug Development

The proceeds from the Rights issue will mainly be used to finance the further clinical development of KL1333 and preparing for the start of clinical Phase II efficacy study of NeuroSTAT, as well as to the Company’s other drug development projects in pre-clinical phase.

February 15, 2018

·

11 min read

Business

Ipsen Delivers Strong 2017 Results with 21.1%1 Sales Growth and Core Operating Margin Increase of 3.4 Points and Expects Significant Further Growth in Sales and Margin in 2018

Full Year 2017 Group sales growth of 21.1%1 driven by Specialty Care sales growth of 25.9%1 reflecting continued Somatuline momentum and increasing contribution from the Cabometyx and Onivyde® launches, and Consumer Healthcare back to growth at 1.4%.

February 15, 2018

·

58 min read

Drug Development

Selumetinib Granted Orphan Drug Designation by the U.S. FDA for Neurofibromatosis Type 1

AstraZeneca and Merck announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for selumetinib, a MEK 1/2 inhibitor, for the treatment of neurofibromatosis type 1 (NF1).

February 15, 2018

·

7 min read

Pharm Country

Realm Therapeutics Highlights Strong 2017 Performance and Outlines 2018 Milestones

Realm Therapeutics today provided a clinical and business update.

February 15, 2018

·

5 min read

Biotech Bay

Data from BioTime’s OpRegen and Vision Restoration Programs to Be Presented at ARVO 2018

BioTime today announced that two abstracts have been accepted and will be presented at the upcoming Association for Research in Vision and Ophthalmology (ARVO) meeting taking place from April 29th – May 3rd, 2018, in Honolulu, Hawaii.

February 15, 2018

·

4 min read

Drug Development

Arrowhead Receives Regulatory Clearance to Begin Phase I/II Study of ARO-HBV for Treatment of Hepatitis B

The company anticipates that dosing will begin around the end of March.

February 15, 2018

·

3 min read

Business

Zoetis Reports Fourth Quarter and Full Year 2017 Results

The company reported revenue of $1.5 billion for the fourth quarter of 2017, which was an increase of 14% compared with the fourth quarter of 2016.

February 15, 2018

·

39 min read

Policy

Edwards’ Self-Expanding Transcatheter Heart Valve Receives CE Mark

The Edwards CENTERA valve is repositionable and retrievable and can be delivered through a low-profile, 14-French, motorized delivery system.

February 15, 2018

·

3 min read